Literature DB >> 18498270

The effect of calcium channel blocker verapamil on gentamicin nephrotoxicity in rats.

Nenad Stojiljković1, Slavimir Veljković, Dragan Mihailović, Milan Stoiljković, Dragan Radovanović, Pavle Randelović.   

Abstract

Aminoglycoside antibiotics are obligated nephrotoxins and inevitably cause renal failure during prolonged use. Experimental models of gentamicin-induced nephrotoxicity have shown histopathological, ultrastructural and functional alteration with blood urea nitrogen and serum creatinine increase leading to acute renal insufficiency (ARI). The aim of our study was to emphasize effects of verapamil, a calcium channel blocker, on gentamicin-induced ARI in rats. Experiments were done on 50 male Wistar rats (250-300 g) divided in three experimental groups. G-group animals (20 rats) were treated daily with gentamicin in dose of 100 mg/kg during 8 days. GV-group animals (20 rats) were treated daily with verapamil in dose of 3 mg/kg and the same dose of gentamicin as in G-group during 8 days. The control group (10 rats) received 1 ml/day saline intraperitoneally. Histological examinations were done using hematoxylin and eosin, periodic acid Schiff and methenamine silver staining methods. Morphometric parameters included measurement of glomerular area, major and minor axis, perimeter, diameter, roundness, and mean optical density. Biochemical analyses were used to determine concentrations of blood urea, serum creatinine, sodium and potassium. In G-group rats' glomerular basement membrane was diffusely and unequally thickened with polymorphonuclear neutrophils infiltration, while coagulation-type necrosis and vacuolization of cytoplasm of proximal tubules epithelial cells were observed. In GV-group rats' glomeruli were slightly enlarged with thickened basement membrane in some segments but without coagulation-type necrosis. Morphometric analyses showed statistically significant differences between the G-group and control group of animals in glomerular size, mean optical density and average roundness (p<0,05). On the other hand, morphometric analyses between GV-group and control group animals did not show statistically significant differences in any of parameters measured. Blood urea and serum creatinine concentration in G-group were significantly elevated in comparison with GV-group (p<0,05) but sodium and potassium levels in G-group were decreased compared to GV-group without statistical significance. Our results show that verapamil modify some of morphological and functional kidney alterations induced by gentamicin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498270      PMCID: PMC5698350          DOI: 10.17305/bjbms.2008.2977

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  14 in total

1.  [Nephrotoxicity of aminoglycosides. II. Preventive studies with oral administration of verapamil].

Authors:  S Niemczyk; A Ludwicka; M Groniowski; Z Lewandowski; Z Hasse; K A Wardyn
Journal:  Pol Arch Med Wewn       Date:  1991-01

2.  Vitamin E and selenium in gentamicin nephrotoxicity.

Authors:  O Ademuyiwa; E O Ngaha; F O Ubah
Journal:  Hum Exp Toxicol       Date:  1990-09       Impact factor: 2.903

3.  Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats.

Authors:  Y Matsumura; M Nishiura; S Deguchi; N Hashimoto; T Ogawa; R Seo
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

4.  Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat.

Authors:  L S Ramsammy; C Josepovitz; K Y Ling; B P Lane; G J Kaloyanides
Journal:  Biochem Pharmacol       Date:  1987-07-01       Impact factor: 5.858

Review 5.  Potential role of platelet activating factor in acute renal failure.

Authors:  J M López-Novoa
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

6.  L-carnitine ameliorates gentamicin-induced renal injury in rats.

Authors:  Joel D Kopple; Hu Ding; Annamaria Letoha; Bela Ivanyi; David Pei-Yuan Qing; Lázló Dux; Hui-Yuan Wang; Sandor Sonkodi
Journal:  Nephrol Dial Transplant       Date:  2002-12       Impact factor: 5.992

7.  Beneficial effect of verapamil in ischemic acute renal failure in the rat.

Authors:  D Goldfarb; A Iaina; I Serban; S Gavendo; S Kapuler; H E Eliahou
Journal:  Proc Soc Exp Biol Med       Date:  1983-03

8.  Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C.

Authors:  M Kavutcu; O Canbolat; S Oztürk; E Olcay; S Ulutepe; C Ekinci; I H Gökhun; I Durak
Journal:  Nephron       Date:  1996       Impact factor: 2.847

9.  Electrolyte composition of renal tubular cells in gentamicin nephrotoxicity.

Authors:  O Matsuda; F X Beck; A Dörge; K Thurau
Journal:  Kidney Int       Date:  1988-06       Impact factor: 10.612

Review 10.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

View more
  3 in total

1.  Garlic (Allium sativum) exhibits a cardioprotective effect in experimental chronic renal failure rat model by reducing oxidative stress and controlling cardiac Na+/K+-ATPase activity and Ca2+ levels.

Authors:  Asmaa M S Gomaa; Alaa T Abdelhafez; Hazem A Aamer
Journal:  Cell Stress Chaperones       Date:  2018-04-21       Impact factor: 3.667

2.  Pentoxifylline ameliorates glomerular basement membrane ultrastructural changes caused by gentamicin administration in rats.

Authors:  Nenad Stojiljković; Slavimir Veljković; Dragan Mihailović; Milan Stoiljković; Goran Ranković; Ivan Jovanović; Pavle Randjelović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

3.  Comparison of the species-sensitive effects of different dosages of calcium and verapamil on gentamicin-induced nephrotoxicity in rats and rabbits.

Authors:  Amol N Patil; Tarun Arora; Amrita Desai; Chakra Dhar Tripathi
Journal:  Toxicol Int       Date:  2014 Sep-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.